From: Bioenzyme-based nanomedicines for enhanced cancer therapy
Therapeutic modality | Nanosystem | Enzyme | Work mechanism | Reference |
---|---|---|---|---|
Chemotherapy | Nanogels | Ribonuclease A | Catalyze RNA degradation | [36] |
Mesoporous silica | Ribonuclease A | Catalyze RNA degradation | [37] | |
Large-pore mesoporous silica | Ribonuclease A | Degrade mRNA and tRNA | [38] | |
Polymer-based nanoparticles | Ribonuclease A | Degrade cellular RNA | [39] | |
Hollow organosilica | Glucose oxidase | Consume glucose | [40] | |
Mesoporous polydopamine | Glucose oxidase | Consume glucose | [41] | |
Liposomes | Glucose oxidase | Consume glucose | [42] | |
Porous silica nanoparticles | Hyaluronidase | Decompose HA-DOX to produce toxic dissociative DOX | [43] | |
Micelles | Collagenase | Digest collagen fibers in tumor ECM | [45] | |
Nanogels | Collagenase | Digest tumor ECM | [46] | |
Heavy-chain ferritin nanocages | Collagenase | Degrade the collagen in tumor ECM | [47] | |
PCL-PEG nanoparticles | Collagenase IV | Degrade the collagen component of ECM | [48] | |
Chitosan nanoparticles | Bromelain | Digest tumor ECM | [49] | |
Hierarchical nanoparticles | Hyaluronidase | Degrade hyaluronic acid in tumor ECM | [51] | |
Micelles | Hyaluronidase | Degrade hyaluronic acid in tumor ECM | [52] | |
PTT | Ultrasmall platinum nanoparticles | Glucose oxidase | Catalyze glucose to produce H2O2 and D-glucono-δ-lactone | [58] |
Semiconducting polymer nanoparticles | Bromelain | Digest collagen in tumor ECM | [59] | |
Gold/mesoporous polydopamine nanoparticles | Papain | Degrade tumor ECM | [60] | |
Liquid metal nanoparticles | Glucose oxidase | Inhibit ATP and HSP levels | [61] | |
Porous hollow Prussian blue nanoparticles | Glucose oxidase | Enhance glucose depletion | [62] | |
Hollow mesoporous silica | Glucose oxidase | Reduce the thermo-resistance and consume glucose | [63] | |
Gold nanoparticles | Myrosinase | convert nontoxic GRE into toxic SFE | [35] | |
Liposomes | Glucose oxidase | Consume glucose and inhibit HSP expression | [64] | |
PDT | Hyaluronic-acid-based nanoparticles | Catalase | Decompose endogenous H2O2 to generate O2 | [69] |
Polymeric micelles | Catalase | Catalyze endogenous H2O2 to generate O2 | [70] | |
Upconversion nanoparticles | Catalase | Catalyze endogenous H2O2 to generate O2 | [71] | |
Mesoporous silica | Glucose oxidase | Catalyze glucose consumption to generates H2O2 | [72] | |
Biomimetic hybrid nanozymes | Glucose oxidase | Oxidize glucose to gluconic acid and H2O2 | [73] | |
Manganese-doped calcium phosphate nanoparticles | Catalase and glucose oxidase | Convert intracellular H2O2 to O2 and intratumoral glucose to H2O2 and gluconic acid | [75] | |
Metal–organic frameworks | Catalase and glucose oxidase | Convert intracellular H2O2 to O2 and consume glucose | [76] | |
Semiconducting polymer nanoparticles | Ribonuclease A | Degrade intracellular RNA | [77] | |
CDT | Metal organic frameworks | Glucose oxidase | Catalyze glucose oxidation to produce H2O2 and gluconic acid | [80] |
Iridium oxide nanoparticles | Glucose oxidase | Oxidize glucose to gluconic acid and H2O2 | [81] | |
Nanogels | Lactate oxidase and catalase | Catalyze lactate to produce H2O2 and decompose H2O2 into O2 | [82] | |
Zeolitic imidazole framework | Catalase and DNAzyme | Silence CAT and deplete GSH | [83] | |
RT | TaOx nanoparticles Cisplatin-prodrug-based liposomes | Catalase Catalase | Degrade H2O2 to generate O2 Degrade H2O2 to generate O2 | [86] [87] |
Immunotherapy | γ-PGA nanoparticles | Glucose oxidase | Deplete glucose | [92] |
Tetraethyl orthosilicate | Catalase | Degrade H2O2 to generate O2 | [93] | |
PLGA nanoparticles | Catalase | Degrade H2O2 to generate O2 | [94] | |
Dextran-conjugated nanoparticles | Hyaluronidase | Degrade hyaluronic acid in tumor CEM | [95] | |
Microneedles | Hyaluronidase | Degrade hyaluronic acid in tumor CEM | [97] | |
Semiconducting polymer nanoparticles | Kynureninase | Degrade the immunosuppressive kynurenine | [99] |